BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 1375120)

  • 21. Characteristics of CD11c+CD5+ chronic B-cell leukemias and the identification of novel peripheral blood B-cell subsets with chronic lymphoid leukemia immunophenotypes.
    Wormsley SB; Baird SM; Gadol N; Rai KR; Sobol RE
    Blood; 1990 Jul; 76(1):123-30. PubMed ID: 1694698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of VH gene expression in CD5+ and CD5- B-cell chronic lymphocytic leukemia.
    Maloum K; Davi F; Magnac C; Pritsch O; McIntyre E; Valensi F; Binet JL; Merle-Béral H; Dighiero G
    Blood; 1995 Nov; 86(10):3883-90. PubMed ID: 7579357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Triggering of neoplastic B cells via surface IgM and the cell surface antigens CD20 and CDw40. Responses differ from normal blood B cells and are restricted to certain morphologic subsets.
    Beiske K; Clark EA; Holte H; Ledbetter JA; Smeland EB; Godal T
    Int J Cancer; 1988 Oct; 42(4):521-8. PubMed ID: 2459071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells.
    Hashimoto S; Dono M; Wakai M; Allen SL; Lichtman SM; Schulman P; Vinciguerra VP; Ferrarini M; Silver J; Chiorazzi N
    J Exp Med; 1995 Apr; 181(4):1507-17. PubMed ID: 7535340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phorbol ester and B cell-stimulatory factor synergize to induce B-chronic lymphocytic leukemia cells to simultaneous immunoglobulin secretion and DNA synthesis.
    Carlsson M; Matsson P; Rosén A; Sundström C; Tötterman TH; Nilsson K
    Leukemia; 1988 Nov; 2(11):734-44. PubMed ID: 3263557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of extensive mutations in the VH5 genes used in common B cell chronic lymphocytic leukemia.
    Rassenti LZ; Kipps TJ
    J Exp Med; 1993 Apr; 177(4):1039-46. PubMed ID: 7681468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phorbol myristate acetate, but not CD40L, induces the differentiation of CLL B cells into Ab-secreting cells.
    Ghamlouch H; Ouled-Haddou H; Guyart A; Regnier A; Trudel S; Claisse JF; Fuentes V; Royer B; Marolleau JP; Gubler B
    Immunol Cell Biol; 2014 Aug; 92(7):591-604. PubMed ID: 24797583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitogen induced activation, proliferation and surface antigen expression patterns in unmutated and hypermutated chronic lymphocytic leukemia cells.
    Vilpo J; Tobin G; Hulkkonen J; Hurme M; Thunberg U; Sundström C; Vilpo L; Rosenquist R
    Eur J Haematol; 2005 Jul; 75(1):34-40. PubMed ID: 15946308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malignant B cell CD5 membrane phenotype and B cell colony growth in vivo and in vitro in patients with B-chronic lymphocytic leukemia: analysis with clinical parameters.
    Hings I; Kay NE; Ranheim E; Seroogy C; Parson RE
    Leuk Lymphoma; 1993 Dec; 12(1-2):59-67. PubMed ID: 7512855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the mRNA expression profile of B-cell receptor components in normal CD5-high B-lymphocytes and chronic lymphocytic leukemia: a key role of ZAP70.
    Gladkikh AA; Potashnikova DM; Tatarskiy V; Yastrebova M; Khamidullina A; Barteneva N; Vorobjev I
    Cancer Med; 2017 Dec; 6(12):2984-2997. PubMed ID: 29125235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histogenesis and pathogenesis of follicular small cleaved cell lymphoma (FSCCL), diffuse small cleaved cell lymphoma (DSCCL) and intermediate lymphocytic lymphoma/lymphocytic lymphoma of intermediate differentiation (ILL/IDL).
    Abe M; Wakasa H
    Fukushima J Med Sci; 1994 Dec; 40(2):85-101. PubMed ID: 7642169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The nature of the B lymphocyte in B-chronic lymphocytic leukemia.
    Caligaris-Cappio F; Gottardi D; Alfarano A; Stacchini A; Gregoretti MG; Ghia P; Bertero MT; Novarino A; Bergui L
    Blood Cells; 1993; 19(3):601-13. PubMed ID: 7517220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Down-regulation of CD5 mRNA in B-chronic lymphocytic leukemia cells by differentiation-inducing agents.
    Gignac SM; Buschle M; Hoffbrand AV; Drexler HG
    Eur J Immunol; 1990 May; 20(5):1119-23. PubMed ID: 1694132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of three subgroups of B cell chronic lymphocytic leukemia based upon mutations of BCL-6 and IgV genes.
    Capello D; Fais F; Vivenza D; Migliaretti G; Chiorazzi N; Gaidano G; Ferrarini M
    Leukemia; 2000 May; 14(5):811-5. PubMed ID: 10803511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What do somatic hypermutation and class switch recombination teach us about chronic lymphocytic leukaemia pathogenesis?
    Oppezzo P; Dighiero G
    Curr Top Microbiol Immunol; 2005; 294():71-89. PubMed ID: 16323428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytokine gene expression in B-cell chronic lymphocytic leukemia: evidence of constitutive interleukin-8 (IL-8) mRNA expression and secretion of biologically active IL-8 protein.
    di Celle PF; Carbone A; Marchis D; Zhou D; Sozzani S; Zupo S; Pini M; Mantovani A; Foa R
    Blood; 1994 Jul; 84(1):220-8. PubMed ID: 7517209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deregulated expression of promyelocytic leukemia zinc finger protein in B-cell chronic lymphocytic leukemias does not affect cyclin A expression.
    Parrado A; Noguera ME; Delmer A; McKenna S; Davies J; Le Gall I; Bentley P; Whittaker JA; Sigaux F; Chomienne C; Padua RA
    Hematol J; 2000; 1(1):15-27. PubMed ID: 11920165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential expression of the Bcl-2 and Bax isoforms in CD19 positive B-lymphocytes isolated from patients diagnosed with chronic lymphocytic leukaemia.
    Ghassemifar R; Forster L; Finlayson J; Calogero T; Augustson B; Joske D; Cull G
    Pathology; 2012 Dec; 44(7):632-7. PubMed ID: 23172082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular investigation of the cytokines produced by normal and malignant B lymphocytes.
    Schena M; Gaidano G; Gottardi D; Malavasi F; Larsson LG; Nilsson K; Caligaris-Cappio F
    Leukemia; 1992 Feb; 6(2):120-5. PubMed ID: 1372670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD5 negative IGM rheumatoid factor B cells in B-chronic lymphocytic leukemia and benign mixed cryoglobulinemia.
    Martin T; Pasquali JL
    Leuk Lymphoma; 1992 May; 7(1-2):55-62. PubMed ID: 1282064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.